Seres Therapeutics, Inc.
MCRB
$4.54
$0.061.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -65.64% | -49.30% | 48.62% | -28.71% | -36.29% |
| Total Receivables | 2,076.92% | -91.56% | -89.12% | -- | -93.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -31.00% | -60.38% | -1.18% | -49.89% | -66.67% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.02% | -51.82% | 27.67% | -29.35% | -67.38% |
|
|
|||||
| Total Current Assets | -13.02% | -51.82% | 27.67% | -29.35% | -67.38% |
| Net Property, Plant & Equipment | -34.08% | -13.78% | -13.33% | -12.81% | -28.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -73.86% | 0.00% | 0.00% | -15.85% | -83.07% |
| Total Assets | -29.35% | -28.36% | -1.16% | -19.73% | -55.30% |
|
|
|||||
| Total Accounts Payable | -46.09% | 7.84% | -58.76% | -79.68% | -54.25% |
| Total Accrued Expenses | -35.63% | -53.97% | -62.94% | -63.98% | -86.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 24.79% | 20.07% | 19.78% | 18.86% | 3.08% |
| Total Finance Division Other Current Liabilities | -75.63% | -76.39% | -81.53% | -85.42% | -73.62% |
| Total Other Current Liabilities | -75.63% | -76.39% | -81.53% | -85.42% | -73.62% |
| Total Current Liabilities | -35.26% | -38.24% | -53.13% | -65.40% | -71.43% |
|
|
|||||
| Total Current Liabilities | -35.26% | -38.24% | -53.13% | -65.40% | -71.43% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -42.51% | -13.50% | -12.52% | -11.65% | -22.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.95% | 12.98% | 13.00% | -57.37% | -97.99% |
| Total Liabilities | -39.51% | -19.87% | -25.43% | -35.55% | -72.88% |
|
|
|||||
| Common Stock & APIC | 2.41% | 2.30% | 2.49% | 1.46% | 3.53% |
| Retained Earnings | -2.33% | -4.96% | 0.58% | 0.56% | 8.18% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.81% | -47.49% | 220.79% | 82.69% | 137.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.81% | -47.49% | 220.79% | 82.69% | 137.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.81% | -47.49% | 220.79% | 82.69% | 137.84% |
|
|
|||||